載入...
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
PURPOSE: Prior phase II studies of intravesical gemcitabine have shown it to be active and well tolerated, but durable responses in patients with nonmuscle invasive bladder cancer who have experienced recurrence after bacillus Calmette-Guérin treatment are uncommon. We performed a multi-institutiona...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4113593/ https://ncbi.nlm.nih.gov/pubmed/23597452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2013.04.031 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|